Technology

Seeing wounds in a new light.

How MolecuLight DX+ fluorescence imaging guides CurePoint wound care.

Most wound assessments rely on visual inspection and clinical signs — but the bacteria driving non-healing wounds are invisible to the naked eye. CurePoint providers use the FDA-cleared MolecuLight DX+™ handheld imaging device to objectively detect, locate, and document elevated bacterial loads at the point of care — without contacting the wound.

White light view — bacteria not visible
White Light — Bacteria Not Visible
MolecuLight DX+ — bacterial load revealed
MolecuLight DX+ — Bacterial Load Revealed

Red = elevated bacterial load >10,000 CFU/g  ·  Cyan = Pseudomonas aeruginosa. Illustrative example — not an actual clinical image.

How CurePoint Providers Use MolecuLight
1

Illuminate

Safe violet light (405 nm) — not UV — applied to the wound bed. No patient contact, no contrast agents, no preparation required.

2

Target

Pinpoints where to debride, where to sample, and whether antimicrobial therapy is warranted.

3

Reveal

Bacterial fluorescence appears instantly: red signals = elevated harmful bacterial loads; cyan signals = Pseudomonas aeruginosa.

4

Measure & Document

Wound area digitally calculated and saved with fluorescence images — accurate baseline at every visit.

Published Clinical Evidence

Wound Healing Rates

Improved with fluorescence-guided care.1

Bacterial Detection

Improved across all skin tones vs. standard visual assessment.2

Antibiotic Stewardship

Guided by real-time bacterial imaging — reducing unnecessary antimicrobial use.3

1. Rahma S. et al. Diabetes Care 2022 — RCT showing improved diabetic foot ulcer healing outcomes with fluorescence-guided care. 2. Johnson J. et al. J Racial and Ethnic Health Disparities 2023 — 350-patient study validating MolecuLight accuracy across all skin tones. 3. Cole W. & Coe S. J Wound Care 2020 — Fluorescence imaging reduced unnecessary antibiotic use and antimicrobial dressing expenditure. MolecuLight DX+™ is FDA-cleared and CE-marked. Fluorescence images should be interpreted in combination with clinical signs and symptoms; not used to rule out bacteria.

Complementary Modalities

Beyond imaging.

Fluorescence imaging pinpoints the problem. These modalities help close it.

Vaporox VHT™

Non-contact ultrasonic mist + concentrated oxygen; 84% healing rate, ~9.4-week closure.

Smith & Nephew PICO™

Canister-free negative pressure wound therapy for postop, DFU, and pressure-injury care.

PointClickCare

Measurements, images, and interventions unify in a record that flows into your system — the most widely used EHR in skilled nursing.

See the technology in your building.

Objective, timestamped documentation that speaks for itself.

Schedule a Walkthrough